Blair Ramirez
Acute Care · Dallas, TXNPI 1548995475
Payments from drug & device makers
What this record shows
This record is dominated by other: $3,147 of the $4,813 with a category attached, or 65.4%. Angiodynamics, Inc. accounts for 65.4% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $3,189, more than ten times the $35 reported in 2022. Among acute care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $85.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$3K
- Smith+Nephew$275
- Kerecis Limited$180
- Tactile Systems Technology Inc$162
- Organogenesis Inc.$150
- Solventum Corporation$143
- plus $756 from 14 others
What the payments were for
- Food & beverage$1,66635%
- Other$3,14765%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 2 | $3,147 |
| Smith+Nephew | 6 | $275 |
| Kerecis Limited | 3 | $180 |
| Tactile Systems Technology Inc | 8 | $162 |
| Organogenesis Inc. | 2 | $150 |
| Solventum Corporation | 3 | $143 |
| AbbVie | 5 | $104 |
| Lifenet Health | 4 | $101 |
| Reapplix Inc. | 1 | $87 |
| KCI USA, Inc. | 4 | $83 |
| Reprise Biomedical, Inc. | 3 | $77 |
| Urgo Medical North America, LLC | 4 | $69 |
| Next Science LLC | 3 | $48 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Boston Scientific | 1 | $34 |
| Mimedx Group, Inc. | 1 | $32 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| Hartmann USA, Inc. | 1 | $21 |
| Inari Medical, Inc. | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,813 in reported general payments places this provider in the 90th percentile of 2,323 acute care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 12 | $412 |
| Doxycycline Hyclate | 21 | $328 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $272 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 24 | $202 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $178 |
| Gabapentin | 20 | $133 |
| Tramadol Hcl | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Other acute care in Dallas
- Jennifer PilotteDallas$232K
- Amanda BradleyDallas$85K
- Martha LibertyDallas$28K
- Rachael SchneiderDallas$20K
- Peter TriporoDallas$15K
- Mario PadillaDallas$13K
- Toni SmithDallas$10K
- Christie MorrisonSan Antonio$225K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.